• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Mylan: Generic Restasis coming in weeks


<















Here you go buddy:

Mylan on go with planned challenge to Allergan's Restasis patents http://www.seekingalpha.com/news/3334170



Really- You send this? Re-read it! This is old news and frankly doesnt say anything about them having FDA approval on a generic Restasis. They submitted an NDA on their version of a generic. Them and perhaps 4 other companies have done that and it means nothing. Nothing coming out in two weeks as some dope has previously stated.